financetom
Business
financetom
/
Business
/
Anthropic settles class action from US authors alleging copyright infringement
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Anthropic settles class action from US authors alleging copyright infringement
Aug 26, 2025 10:42 AM

(Reuters) -Artificial intelligence company Anthropic said in a court filing on Tuesday it had settled a class action lawsuit from a group of U.S. authors who argued the company's AI training infringed their copyrights.

Details of the settlement were not immediately available.

A California judge said in a June ruling that Anthropic may have illegally downloaded as many as 7 million books from pirate websites, which could have made it liable for billions of dollars in damages if the authors' case was successful. 

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
--Street Color: Estee Lauder Appoints Stephane De La Faverie as New CEO, Wall Street Journal Reports
--Street Color: Estee Lauder Appoints Stephane De La Faverie as New CEO, Wall Street Journal Reports
Nov 3, 2024
01:13 PM EDT, 10/28/2024 (MT Newswires) -- Price: 89.11, Change: +1.86, Percent Change: +2.13 ...
Why Is Moderna Stock Trading Higher On Monday?
Why Is Moderna Stock Trading Higher On Monday?
Nov 3, 2024
On Monday, Merck & Co Inc ( MRK ) and Moderna, Inc. ( MRNA ) announced the initiation of INTerpath-009, a pivotal Phase 3 trial of V940 (mRNA-4157). V940 is an investigational individualized neoantigen therapy under development in combination with Keytruda (pembrolizumab) as adjuvant treatment for resectable Stage II, IIIA or IIIB (N2) non-small cell lung cancer (NSCLC) patients who did not...
BMO on Corus Entertainment's Q4
BMO on Corus Entertainment's Q4
Nov 3, 2024
12:52 PM EDT, 10/28/2024 (MT Newswires) -- Corus Entertainment fourth quarter results missed and the advertising outlook continues to look bleak with advertising market challenges and reprogramming risks, notes BMO. Quarterly revenue fell 21% (5% below expectations) while EBITDA was -9% (-0.5% below). Television advertising revenue declined -16%. Adj. EPS was -$0.02 vs. -$0.07 Street. BMO notes that the company...
AbbVie Acquires Aliada Therapeutics for $1.4 Billion to Boost Neuroscience Portfolio
AbbVie Acquires Aliada Therapeutics for $1.4 Billion to Boost Neuroscience Portfolio
Nov 3, 2024
12:45 PM EDT, 10/28/2024 (MT Newswires) -- AbbVie ( ABBV ) announced an agreement to buy Aliada Therapeutics and its Alzheimer's disease candidate for $1.4 billion in cash to boost its neuroscience portfolio. The pharmaceutical company will gain access to Aliada's lead investigational asset, ALIA-1758, which is an anti-pyroglutamate amyloid beta antibody being developed as a treatment for Alzheimer's. Shares...
Copyright 2023-2026 - www.financetom.com All Rights Reserved